Steven Park to Antineoplastic Agents
This is a "connection" page, showing publications Steven Park has written about Antineoplastic Agents.
Connection Strength
0.946
-
Moore DC, Elmes JB, Shibu PA, Larck C, Park SI. Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Ann Pharmacother. 2020 Apr; 54(4):371-379.
Score: 0.474
-
Park SI, Lin CP, Ren N, Angus SP, Dittmer DP, Foote M, Parton T, Bhatt AP, Fedoriw YD, Roth DP, Cann ML, Johnson GL, Damania B. Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma. Target Oncol. 2019 Oct; 14(5):563-575.
Score: 0.472